Bank of America Lowers CVS Health (NYSE:CVS) Price Target to $95.00

CVS Health (NYSE:CVS) had its price objective lowered by investment analysts at Bank of America from $100.00 to $95.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the pharmacy operator’s stock. Bank of America‘s target price points to a potential upside of 28.14% from the company’s previous close.

Several other equities research analysts also recently commented on the company. Robert W. Baird increased their price objective on CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a report on Wednesday, December 10th. Evercore ISI increased their price target on shares of CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Piper Sandler restated an “overweight” rating and set a $101.00 price objective (up from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. Argus raised their target price on shares of CVS Health from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, November 4th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. Twenty analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $94.82.

CVS Health Stock Up 3.0%

CVS stock opened at $74.14 on Tuesday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. The stock has a market capitalization of $94.12 billion, a P/E ratio of 195.11, a P/E/G ratio of 0.66 and a beta of 0.48. CVS Health has a fifty-two week low of $53.36 and a fifty-two week high of $85.15. The business has a 50-day moving average of $79.01 and a 200-day moving average of $75.02.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. During the same quarter in the prior year, the company posted $1.09 earnings per share. The firm’s revenue was up 7.8% on a year-over-year basis. On average, sell-side analysts anticipate that CVS Health will post 5.89 earnings per share for the current fiscal year.

Institutional Trading of CVS Health

A number of institutional investors and hedge funds have recently made changes to their positions in CVS. ORG Partners LLC grew its position in CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 377 shares during the last quarter. Sound Income Strategies LLC increased its stake in shares of CVS Health by 32.3% in the second quarter. Sound Income Strategies LLC now owns 2,774 shares of the pharmacy operator’s stock valued at $191,000 after buying an additional 677 shares during the period. GC Wealth Management RIA LLC raised its holdings in CVS Health by 34.3% in the 2nd quarter. GC Wealth Management RIA LLC now owns 9,053 shares of the pharmacy operator’s stock valued at $624,000 after buying an additional 2,312 shares during the last quarter. Centennial Wealth Advisory LLC acquired a new stake in CVS Health during the 2nd quarter worth approximately $519,000. Finally, Poinciana Advisors Group LLC grew its holdings in CVS Health by 51.1% during the 2nd quarter. Poinciana Advisors Group LLC now owns 5,036 shares of the pharmacy operator’s stock worth $347,000 after acquiring an additional 1,704 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS shares rose while the broader market fell, reflecting short-term buying interest and risk-on flows. Zacks Article
• Positive Sentiment: Short interest fell ~13.4% in January to ~18.76M shares (1.5% of float), lowering potential downward pressure from short sellers and reducing squeeze risk (days-to-cover ~2.5). Short Interest Data
• Positive Sentiment: An executive vice president disclosed a small open-market buy (24 shares at ~$53.70 on Jan. 23), a modest insider signal of confidence. SEC Form 4
• Neutral Sentiment: Analysts at Argus cut their price target slightly from $91 to $90 but kept a “buy” rating (still showing material upside), signaling continued analyst support despite the trim. The Fly
• Neutral Sentiment: Bank of America lowered its target from $100 to $95 but maintained a “buy” stance, also implying continued conviction in longer-term upside despite near-term adjustments. Benzinga
• Negative Sentiment: The administration’s proposal to keep Medicare rates roughly flat has pressured Medicare-related revenue expectations for payers and pharmacy benefit managers, contributing to earlier selloffs and ongoing margin concerns for CVS. Barron’s
• Negative Sentiment: A House Judiciary report and related coverage allege CVS used tactics to limit competition from rival pharmacy hubs, introducing regulatory and legal risk that could increase compliance costs or fines. HealthcareDive

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.